FAQ/Help |
Calendar |
Search |
Today's Posts |
05-04-2019, 09:51 AM | #1 | ||
|
|||
Member
|
As John posted on in the previous thread, the isradipine trial results have been released. Unfortunately the drug had no significant benefits. As this was a very closely watched trial by the PD community, it's sad and I thought it deserved discussion on a new thread.
Well, onto the next trial. One of these days we will succeed! Gary Calcium Channel Blocker Flops in Parkinson's Disease Trial | Medpage Today |
||
Reply With Quote |
"Thanks for this!" says: | soccertese (05-05-2019) |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Trial Fails to Show Benefits of Hydrogen-saturated Water in Parkinson’s Patients | Parkinson's Disease | |||
Recruitment Begins for STEADY-PD Phase III Trial of Isradipine | Parkinson's Disease | |||
Glutathione Fails to Demonstrate Significant Improvement in Parkinson’s Disease Sympt | Parkinson's Disease | |||
Isradipine Clinical Trial - FYI | Parkinson's Disease | |||
Isradipine Clinical Trial | Parkinson's Disease |